Cymbalta vs. Pristiq
See how Cymbalta and Pristiq compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Cymbalta and Pristiq are both SNRIs used for depression, but Cymbalta is also approved for anxiety and several chronic pain conditions, while Pristiq's approval is limited to major depressive disorder in adults.
Cymbalta requires a titration schedule moving from 30 mg to 60 mg daily, while Pristiq is typically prescribed at a single 50 mg dose with no titration needed.
Both drugs share nausea and dizziness as common side effects, but Pristiq's nausea rate (up to 41%) runs notably higher than Cymbalta's (up to 30%).
Cymbalta vs. Pristiq Drug Summary
Cymbalta
Cymbalta (duloxetine) is a serotonin-norepinephrine reuptake inhibitor (SNRI) that treats depression, anxiety, and chronic pain conditions like diabetic nerve pain and fibromyalgia. It comes as a delayed-release capsule, with the dose increased gradually from 30 mg to 60 mg daily.
Pristiq
Pristiq (desvenlafaxine) is an SNRI approved specifically for major depressive disorder in adults, without Cymbalta's broader pain approvals. It comes as an extended-release tablet taken once daily at a fixed 50 mg dose, with no titration needed.
Cymbalta vs. Pristiq Side Effects
Cymbalta
Pristiq
Cymbalta vs. Pristiq Dosage
Cymbalta
Pristiq
| STAGE | DOSE | WHEN |
| Starting dose | 30 mg once daily | Week 1 |
| Maximum dose | 60 mg once daily | Week 2 onward |
| Dose changes | 1 increase | Every week |
| STAGE | DOSE | WHEN |
| Starting dose | 50 mg once daily | Day 1 onward |
| Maximum dose | 50 mg once daily | Same as starting |
| Dose changes | None | Fixed dose |
Cymbalta
| STAGE | DOSE | WHEN |
| Starting dose | 30 mg once daily | Week 1 |
| Maximum dose | 60 mg once daily | Week 2 onward |
| Dose changes | 1 increase | Every week |
Pristiq
| STAGE | DOSE | WHEN |
| Starting dose | 50 mg once daily | Day 1 onward |
| Maximum dose | 50 mg once daily | Same as starting |
| Dose changes | None | Fixed dose |
Cymbalta vs. Pristiq Indications
Cymbalta
Cymbalta is FDA-approved for major depressive disorder, generalized anxiety disorder, and several chronic pain syndromes, making it one of the few antidepressants with pain-specific approvals. This dual action can help patients managing both mood symptoms and physical pain with a single medication.
Major depressive disorder
Generalized anxiety disorder
Diabetic peripheral neuropathic pain
Fibromyalgia
Pristiq
Pristiq is FDA-approved only for major depressive disorder in adults, with no anxiety or pain indications. It offers a simpler treatment profile focused solely on mood symptoms, using a single standard dose for most patients.
Major depressive disorder in adults
50 mg once daily is both the starting and target dose
Not approved for anxiety, chronic pain, or pediatric use
Higher doses showed no added efficacy benefit
Cymbalta vs. Pristiq Pros and Cons
Cymbalta
Cymbalta's approval for chronic pain conditions alongside depression and anxiety gives it broader clinical use than many SNRIs. That flexibility comes with a more involved titration process and stricter warnings around liver and kidney function.
Pros
FDA-approved for chronic pain conditions like diabetic neuropathy and fibromyalgia, not just depression
Long-standing safety record, approved since 2004
Dosing can be split twice daily for patients sensitive to peak-level side effects
Broader indication list allows treating overlapping mood and pain symptoms with one drug
Cons
Requires several weeks of titration before reaching the maintenance dose
Must be avoided entirely in patients with liver disease or severe kidney impairment
More complex dosing options at higher doses may reduce adherence
Metabolized by CYP1A2 and CYP2D6, raising interaction risk with certain drugs
Pristiq
Pristiq's single fixed dose makes it simpler to start and manage than many SNRIs, but its FDA approval is limited strictly to depression. As the active metabolite of venlafaxine, it may suit patients who previously responded to Effexor.
Pros
Single fixed dose (50 mg) simplifies treatment without titration
Active metabolite of venlafaxine, may suit patients who tolerated Effexor
Generic desvenlafaxine available, lowering cost compared to brand-name Pristiq
Simpler side-effect monitoring with no dose-related adjustments needed
Cons
Approved only for adult depression, not anxiety or chronic pain
Higher doses show no added benefit, limiting options for partial responders
No established use for anxiety, pain, or other off-label conditions common with SNRIs
Requires dose adjustment in kidney impairment rather than simple avoidance
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.